Figure 1.

(a) The values of COVID-19 NT₅₀ in different groups of patients. The median (interquartile) antibody value of post-vaccination serum NT₅₀ were 279.3 (50.61–465.04) IU/mL in the DS group of patients, which was higher than 82.93 (22.63–229.37) IU/mL in SS group of patients (p = 0.029) and 25.09 (9.62–455.27) IU/mL in NA group patients (p = 0.004), and also had a tendency higher than 145.61 (15.02–455.27) IU/mL in MT group patients (p = 0.052). (b) The liver function tests before and after the vaccinations in DS group patients. The median (interquartile, range) of AST was 20 (16–30.8, 9–316) U/L after vaccinations compared to 19.5 (16–27.8, 10–78) before vaccinations (p = 0.200). The median (interquartile, range) of ALT was 20.5 (12–34.8, 6–581) U/L after vaccinations compared to 19.5 (13–30, 2–141) before vaccinations (p = 0.089). (B, before vaccination; A, after vaccination).